Abstract:Background D‐dimer is involved in poor outcomes of stroke as a coagulation biomarker. We aimed to investigate the associations of the level and increase in D‐dimer between baseline and 90 days with all‐cause death or poor functional outcome in patients after ischemic stroke or transient ischemic attack. Methods and Results We collected data from the CNSRIII (Third China National Stroke Registry) study. The present substudy included 10 518 patients within 7 days (baseline) of ischemic stroke or transient ischemic attack and 6268 patients at 90 days. Poor functional outcome at 1 year was assessed on the basis of the modified Rankin Scale (≥3). Multivariable Cox regression or logistic regression was used to assess the association of D‐dimer levels with all‐cause death or poor functional outcome. D‐dimer levels at 90 days were lower than those at baseline (1.4 μg/mL versus 1.7 μg/mL; P <0.001). Higher baseline D‐dimer level was associated with all‐cause death (adjusted hazard ratio [HR], 1.77; 95% CI, 1.25–2.52; P =0.001) and poor functional outcome (adjusted odds ratio [OR], 1.49; 95% CI, 1.23–1.80; P <0.001) during 1‐year follow‐up. Higher D‐dimer level at 90 days was also associated with poor outcomes independently. Furthermore, an increase in D‐dimer levels between baseline and 90 days was associated with all‐cause death (since 90 days to 1 year after index event) (adjusted HR, 1.99; 95% CI, 1.12–3.53; P =0.019) but not with poor functional outcome (adjusted OR, 1.08; 95% CI, 0.82–1.41). Conclusions Our study shows that high level and an increase in D‐dimer between baseline and 90 days are associated with poor outcomes in patients after ischemic stroke or transient ischemic attack. Nonstandard Abbreviations and Acronyms CNSRIII Third China National Stroke Registry mRS modified Rankin Scale NIHSS National Institutes of Health Stroke Scale TOAST Trial of Org 10172 in Acute Stroke Treatment Clinical Perspective What Is New? Baseline and 90‐day D‐dimer levels were associated with all‐cause death and poor functional outcome in a large population with ischemic stroke or transient ischemic attack. An increase in D‐dimer levels was associated with all‐cause death after ischemic stroke or transient ischemic attack. What Are the Clinical Implications? Dynamic measurements of D‐dimer levels might be helpful for identifying patient with stroke or transient ischemic attack at a higher risk of recurrent events. It is uncertain if patients with stroke or transient ischemic attack and an elevated D‐dimer may benefit from more aggressive antithrombotic or anticoagulant measures for secondary stroke prevention. Cerebrovascular disease is the leading cause of death and disability in China, with the majority of cases (69.6%–70.8%) involving ischemic stroke and transient ischemic attack (TIA). 1 , 2 Identifying potential risk factors of poor outcomes and developing targeted therapeutics are critical. In particular, we recently reported that lipid metabolism and inflammatory factors were associated with stroke outcomes. 3 , 4 , 5 D‐dimer, which is a fibrin degradation product, is a biomarker for coagulation and reflects increased thrombosis. 6 , 7 Although D‐dimer level has been clearly confirmed to be associated with death in the general population in the long term, 8 , 9 only a few studies assessed the association of D‐dimer with death 10 , 11 , 12</s -Abstract Truncated-

D-dimer is a Predictor of 28-Day Mortality in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.

Elevated D-Dimer Levels Correlate with the Development of Hepatorenal Syndrome and a Poor Outcome in Patients with Cirrhosis

The prognostic value of admission D-dimer level in patients with cardiogenic shock after acute myocardial infarction

D-Dimer Levels and the Risk of 30-Day All-Cause Mortality in Cardiogenic Shock Stratified by Etiology

Association between D-dimer-to-albumin ratio and 28-days all-cause mortality in patients with sepsis

Clinical analysis of continuous renal replacement therapy in patients with acute kidney injury in ICU

D-dimer Level for Predicting the In-Hospital Mortality in Liver Cirrhosis: A Retrospective Study.

Association of Level and Increase in D-Dimer With All-Cause Death and Poor Functional Outcome After Ischemic Stroke or Transient Ischemic Attack.

Elevated D‐dimer Levels Predict Adverse Outcomes in Hospitalised Elderly Patients with Chronic Heart Failure

Serum D-dimer Levels at Admission for Prediction of Outcomes in Acute Pancreatitis

D-Dimer as a Predictor of Disease Outcome in Intensive Care SARS-COV-2 Patients: A Retrospective Study

A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19

D-dimer as a Marker of Severity and Prognosis in Acute Pancreatitis

Elevated D-dimer increases the risk of dialysis after surgery in patients with Stanford A aortic dissection through the impact of the coagulation system.

Plasma D-Dimer Predicts Short-Term Poor Outcome after Acute Ischemic Stroke

The Value of D-Dimer Level in Predicting Contrast-Induced Acute Kidney Injury in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI

Prognostic capacity of D-dimer in predicting mortality in patients diagnosed with COVID-19

D-Dimer to Fibrinogen Ratio As a Novel Prognostic Marker in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.

Plasma D‐dimer Predicts Poor Outcome and Mortality after Spontaneous Intracerebral Hemorrhage

The value of D-dimer in the prognosis of dilated cardiomyopathy: a retrospective cohort study

D-dimer is a prognostic marker for 1-year mortality in patients with chronic liver failure and hepatic encephalopathy